Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
72.93
-2.04 (-2.72%)
At close: Oct 17, 2025, 4:00 PM EDT
73.99
+1.06 (1.45%)
Pre-market: Oct 20, 2025, 8:00 AM EDT
Tarsus Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$69.43
Upside
-4.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $88 | Strong Buy | Maintains | $72 → $88 | +20.66% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | -1.28% | May 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $46 → $51 | Hold | Maintains | $46 → $51 | -30.07% | May 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $78 → $84 | Strong Buy | Maintains | $78 → $84 | +15.18% | May 2, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $54 → $58 | Strong Buy | Maintains | $54 → $58 | -20.47% | Mar 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $75 → $78 | Strong Buy | Maintains | $75 → $78 | +6.95% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +0.10% | Feb 26, 2025 |
| Barclays | Barclays | Buy Maintains $62 → $60 | Buy | Maintains | $62 → $60 | -17.73% | Feb 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | -14.99% | Jan 27, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $65 → $72 | Buy | Maintains | $65 → $72 | -1.28% | Jan 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $41 | Hold | Maintains | $36 → $41 | -43.78% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $63 → $65 | Buy | Maintains | $63 → $65 | -10.87% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $61 → $63 | Buy | Reiterates | $61 → $63 | -13.62% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $61 | Strong Buy | Maintains | $57 → $61 | -16.36% | May 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.